食品伙伴網(wǎng)訊  據(jù)美國(guó)食品藥品管理局（FDA）消息，近來美國(guó)FDA接連收到咨詢有關(guān)轉(zhuǎn)基因食品標(biāo)識(shí)的問題，4月8日美國(guó)FDA就轉(zhuǎn)基因標(biāo)識(shí)發(fā)布聲明稱，F(xiàn)DA對(duì)"轉(zhuǎn)基因標(biāo)識(shí)"奉行自愿標(biāo)注的原則，然而產(chǎn)品標(biāo)識(shí)必須真實(shí)且不能誤導(dǎo)消費(fèi)者。美國(guó)FDA認(rèn)為，轉(zhuǎn)基因食品與傳統(tǒng)食品一樣，符合安全要求。

    部分原文報(bào)道如下：

    FDA has recently received inquiries about the labeling of foods with ingredients derived from genetically engineered plants.

    We recognize and appreciate the strong interest that many consumers may have in knowing whether a food was produced using genetic engineering.  FDA supports voluntary labeling for food derived from genetic engineering.  Currently, food manufacturers may indicate through voluntary labeling whether foods have or have not been developed through genetic engineering provided that such labeling is truthful and not misleading. 

    Recently, FDA has received citizen petitions regarding genetically engineered foods, including the labeling of such foods.  The agency is currently considering those petitions, and at this time, has not made a decision, in whole or in part, regarding the petitions.

    FDA's role generally is to ensure that foods under its purview meet applicable safety, labeling, and other regulatory requirements.  In general, foods derived from genetically engineered plants must meet the same requirements, including safety requirements, as other foods, such as foods derived from traditionally bred plants.

    原文鏈接：http://www.fda.gov/Food/FoodScienceResearch/Biotechnology/ucm346858.htm